Vaccines

Throughout the COVID-19 pandemic, World TB Day, which is observed each year on March 23, has marked the need for more — more research, more testing, more treatment options, and more access for patients globally.

The concept of cancer vaccination has generated excitement in the scientific community for decades.

Currently, the Bacillus Calmette-Guérin vaccine from 1921 is the only available vaccine for tuberculosis, according to a press release from the European Society of Clinical Microbiology and Infectious Diseases.

People with HIV were nearly 50% more likely to receive influenza vaccination than people without, although patients with more complex health care needs had reduced uptake, according to a study from Kaiser Permanente Northern California.

Researchers at Cleveland Clinic intend to expand their study of a novel vaccine designed to prevent triple-negative breast cancer.

An FDA advisory committee recommend the approval of two respiratory syncytial virus vaccines for older people, who are among the most susceptible to severe disease, hospitalization and death from the infection.

SEATTLE — Study findings presented Wednesday at the Conference on Retroviruses and Opportunistic Infections provided more evidence of the effectiveness of vaccines against mpox.

An experimental vaccine against Marburg virus showed promise in a first-in-human phase 1 trial and could one day be used to stop outbreaks of the disease, the NIH said.

An FDA advisory committee voted unanimously Thursday in favor of a plan to streamline and simplify COVID-19 vaccine compositions in the United States by replacing initial, primary doses with the bivalent vaccines currently used as boosters.

Moderna announced Tuesday that its RNA-based respiratory syncytial virus vaccine has met primary endpoints in a phase 3 trial showing that the vaccine is both safe and highly effective in older adults.